# Review of the role of the sentinel node biopsy in neoadjuvant chemotherapy in women with breast cancer and negative or positive axillary node at diagnosis.

**Autores:** Ruano P&#xe9;rez R, Rebollo Aguirre A C, Garc&#xed;a-Talavera San Miguel P et al
**Revista:** Rev Esp Med Nucl Imagen Mol (Engl Ed) (2017)
**PMID:** 28869178 | **PMCID:** —
**DOI:** [10.1016/j.remn.2017.06.007](https://doi.org/10.1016/j.remn.2017.06.007)
**Fuente:** PubMed (abstract only — full text vía DOI)

## Relevancia
Estudio sobre manejo axilar post-NAC en cáncer de mama cN+. Predictores y manejo de pacientes que alcanzan ypN0.

## Abstract
The role of the selective sentinel node biopsy (SNB) is increasing in relevance in breast cancer women with indication of neoadjuvant chemotherapy (NAC). The Radiosurgery Working Group of the SEMNIM is aware of the necessity of establishing the need for SNB before or after NAC, and also how to manage patients with axillary node-negative or node-positive. There is sufficient data to assess that the SNB with radioisotope techniques are feasible and safe in all these scenarios. An adequate axilla evaluation prior to surgery and the possibility of marking prior to NAC the nodes infiltrated must be the two main pillars to guarantee the success of the SNB. It has been shown that to incorporate the SNB in breast cancer women with indication of NAC increases the rate of a conservative treatment of the axilla that will be a clear benefit for these patients.

## Acceso
Artículo no disponible en PMC. Acceder vía [DOI](https://doi.org/10.1016/j.remn.2017.06.007) o suscripción institucional.

---
*Datos de PubMed. Citar: doi 10.1016/j.remn.2017.06.007*
